Biotricity (NASDAQ:BTCY) reported its Q4 earnings results on Friday, June 30, 2023 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Biotricity beat estimated earnings by 11.11%, reporting an EPS of $-0.08 versus an estimate of $-0.09.
Revenue was up $590 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 3.33% drop in the share price the next day.
Here’s a look at Biotricity’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.090 | -0.070 | -0.110 | -0.11 |
| EPS Actual | -0.079 | -0.082 | -0.085 | -0.11 |
| Revenue Estimate | 2.40M | 2.54M | 2.19M | 2.04M |
| Revenue Actual | 2.46M | 2.38M | 2.06M | 2.15M |
To track all earnings releases for Biotricity visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
